Medication info
Elzatang Tablet (Losartan Potassium)

Elzatang Tablet (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tablet
Manufacturer / importer
Dongwha Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200500713 · Notified 2005.06.29 · Insurance code 642702570

Summary

Main use
Treatment of kidney disease in patients with hypertension or type 2 diabetes mellitus accompanied by hypertension
Who takes it
Adults · Children
Adult dose
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after initiation of treatment. If the therapeutic effect is insufficient, the same dose may be divided and administered orally twice daily or, if necessary, increased to 100 mg once daily. 3) If blood pressure is not controlled with this medicine alone, it may be administered in combination with other antihypertensive agents (e.g., a low-dose diuretic). An additive effect has been observed when administered in combination with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered in combination with insulin and commonly used antidiabetic agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). 3. Special patient populations 1) Older adults No adjustment of the initial dose is necessary in older adults aged 75 years or younger. For older adults over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with decreased effective intravascular volume For patients who may have decreased effective intravascular volume (e.g., patients receiving diuretic therapy), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). 4) Patients with hepatic impairment A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
Children and adolescents aged 6 years and older who weigh 20 kg or more and less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Not recommended for children under 6 years of age, pediatric patients with a glomerular filtration rate of less than 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.

Ingredients

Manufacturer
Dongwha Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of kidney disease in patients with hypertension or type 2 diabetes mellitus accompanied by hypertension

  • Hypertension
  • kidney disease in patients with type 2 diabetes
View approved original text

This medication is used for the treatment of hypertension, particularly helping to prevent and treat kidney disease in patients with type 2 diabetes who have hypertension. It controls blood pressure to reduce the risk of cardiovascular complications and is also effective in protecting kidney function. Therefore, it plays an important role in preventing kidney damage caused by hypertension and diabetes.

How to take

Adult dose

This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after initiation of treatment. If the therapeutic effect is insufficient, the same dose may be divided and administered orally twice daily or, if necessary, increased to 100 mg once daily. 3) If blood pressure is not controlled with this medicine alone, it may be administered in combination with other antihypertensive agents (e.g., a low-dose diuretic). An additive effect has been observed when administered in combination with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered in combination with insulin and commonly used antidiabetic agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). 3. Special patient populations 1) Older adults No adjustment of the initial dose is necessary in older adults aged 75 years or younger. For older adults over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with decreased effective intravascular volume For patients who may have decreased effective intravascular volume (e.g., patients receiving diuretic therapy), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). 4) Patients with hepatic impairment A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

Children and adolescents aged 6 years and older who weigh 20 kg or more and less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Not recommended for children under 6 years of age, pediatric patients with a glomerular filtration rate of less than 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.

Precautions

This drug may cause severe harm to the fetus if taken during pregnancy, particularly in the second and third trimesters, and should not be used by pregnant women or those who may become pregnant. Patients with severe liver or kidney dysfunction, history of angioedema, or specific genetic lactose intolerance should not take this medication. Elderly patients, those with hyperkalemia, mild to moderate liver impairment, and patients with valvular heart disease or cardiovascular diseases should use this drug with caution, and especially patients with compromised kidney function should frequently check their serum potassium levels. This medication is generally well tolerated, but side effects such as dizziness, muscle pain, lower back pain, cough, and dyspepsia may occur, and rarely angioedema, liver function abnormalities, and muscle damage may happen, necessitating immediate consultation with a physician if abnormal symptoms arise. Patients with poor liver function may have elevated drug levels, so treatment should start with a lower dose, closely observing the condition. As this drug may interact with other medications, caution is advised when taken with potassium-sparing diuretics or potassium supplements, non-steroidal anti-inflammatory drugs (NSAIDs), lithium, etc., and it is advisable to avoid grapefruit juice. This medication is not recommended for breastfeeding women and should not be used in children under 6 years of age or in children and adolescents with severely impaired kidney function. Regular monitoring of blood pressure, kidney function, and electrolyte levels is necessary during treatment, and if symptoms of hypotension or renal failure occur, medical assistance should be sought immediately. Keep this medication out of reach of children, and do not transfer it to another container.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • muscle spasms
  • lumbago
  • leg pain
  • dizziness
  • congestion
  • upper respiratory infection
Show 136 more
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus disorder
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • bloating
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm desquamation
  • hemolysis
  • facial edema
  • fever
  • orthostatic effect
  • syncope
  • angina
  • second-degree AV block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • arrhythmia
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • anorexia
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthralgia
  • arthritis
  • fibromyalgia
  • muscle weakness
  • anxiety
  • anxiety disorders
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory impairment
  • decreased libido
  • memory impairment
  • migraine
  • neuroirritability
  • sensory disturbances
  • peripheral neuropathy
  • panic disorder
  • sleep disorders
  • hypersomnia
  • tremors
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • hair loss
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • flushing
  • photosensitivity reaction
  • itching
  • rash
  • sweating
  • urticaria
  • blurred vision
  • eye burning
  • eye pain
  • conjunctivitis
  • taste disturbances
  • tinnitus
  • vision impairment
  • erectile dysfunction
  • nocturia
  • frequenct urination
  • urethral infection
  • vascular edema
  • vasculitis
  • anaphylaxis-like syndrome
  • impaired liver function
  • hepatitis
  • intestinal vascular edema
  • malaise
  • thrombocytopenia
  • myalgia
  • weakness
  • elevated creatine kinase
  • rhabdomyolysis
  • taste disturbances
  • dry cough
  • erythroderma
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • increased BUN
  • increased serum creatinine
  • decreased hemoglobin
  • decreased hematocrit
  • elevated liver enzymes
  • increased serum bilirubin
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular ectopy
  • atrial fibrillation
  • hypoglycemia
  • hypotension
  • tachycardia
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This drug may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained between 1°C and 30°C. Proper storage helps to safely maintain the drug's efficacy.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.